Literature DB >> 15041029

Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2.

Christina C Leslie1.   

Abstract

Cytosolic phospholipase A(2) alpha (cPLA(2)alpha) is the only PLA(2) that exhibits specificity for sn-2 arachidonic acid consistent with its primary role in mediating the agonist-induced release of arachidonic acid for eicosanoid production. It is subject to complex mechanisms of regulation that ensure that levels of free arachidonic acid are tightly controlled. The calcium-induced translocation of cPLA(2)alpha from the cytosol to membrane regulates its interaction with phospholipid substrate. cPLA(2)alpha is additionally regulated by phosphorylation on sites in the catalytic domain. Because of its central position as the upstream regulatory enzyme for initiating production of several classes of bioactive lipid mediators (leukotrienes, prostaglandins and platelet-activating factor), it is a potentially important pharmacological target for the control of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041029     DOI: 10.1016/j.plefa.2003.12.012

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  49 in total

1.  Lipid targeting domain with dual-membrane specificity that expands the diversity of intracellular targeting reactions.

Authors:  Joseph J Falke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-26       Impact factor: 11.205

Review 2.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

3.  Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function.

Authors:  Dawn E Tucker; Moumita Ghosh; Farideh Ghomashchi; Robyn Loper; Saritha Suram; Bonnie St John; Milena Girotti; James G Bollinger; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

4.  Arachidonic acid release mediated by OX1 orexin receptors.

Authors:  Pauli M Turunen; Marie E Ekholm; Pentti Somerharju; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

5.  Self-induced docking site of a deeply embedded peripheral membrane protein.

Authors:  Simon Jaud; Douglas J Tobias; Joseph J Falke; Stephen H White
Journal:  Biophys J       Date:  2006-10-27       Impact factor: 4.033

6.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

Authors:  Tatjana Pecaric-Petkovic; Svetlana A Didichenko; Sacha Kaempfer; Nicole Spiegl; Clemens A Dahinden
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

7.  Group IVC cytosolic phospholipase A2gamma is farnesylated and palmitoylated in mammalian cells.

Authors:  Dawn E Tucker; Allison Stewart; Laxman Nallan; Pravine Bendale; Farideh Ghomashchi; Michael H Gelb; Christina C Leslie
Journal:  J Lipid Res       Date:  2005-08-01       Impact factor: 5.922

8.  Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.

Authors:  Georgia Antonopoulou; Efrosini Barbayianni; Victoria Magrioti; Naomi Cotton; Daren Stephens; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

9.  Regulation of connexin36 gap junction channels by n-alkanols and arachidonic acid.

Authors:  Alina Marandykina; Nicolás Palacios-Prado; Lina Rimkutė; Vytenis A Skeberdis; Feliksas F Bukauskas
Journal:  J Physiol       Date:  2013-02-18       Impact factor: 5.182

10.  Off-target effect of the cPLA2α inhibitor pyrrophenone: Inhibition of calcium release from the endoplasmic reticulum.

Authors:  Bogeon Yun; HeeJung Lee; Heather Ewing; Michael H Gelb; Christina C Leslie
Journal:  Biochem Biophys Res Commun       Date:  2016-09-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.